|
Acute coronary syndrome (ACS) develops when there is a decrease of oxygen to the heart for a prolonged period of time, which may lead to a heart attack. Every day, medical researchers are working to develop new treatments that can help patients with ACS manage their condition both safely and more effectively. A clinical research study is being conducted world-wide to assess the effectiveness of an orally administered, investigational medication in patients who have recently suffered a heart attack.
|
To qualify for this study, you must:
- Be at least 45 years old
- Have had a heart attack within the past 2 months
You will not qualify if you:
- Have symptomatic congestive heart failure (CHF)
- Have liver disease
- Are pregnant or nursing
What will be expected of you if you participate?
- Read the informed consent
- Discuss your medical history
- Undergo study-related physical exams and blood draws
- Visit the study center at least 11 times over a period of approximately 2 years. Initially, you will need to visit the study center every few weeks, however, as the study progresses you will only need to visit the study center once every 3 or 4 months.
- Take study medication as directed
|
*Participation in the self-screening questionnaire is intended for US residents only.* |
|
|
|
